Table 5. Structure–activity relationship of tetrahydropyran–tetrahydrofuran-based protease inhibitors.

Compound Ligand number		Ki (nM)	IC50 (nM)
33		0.0027	0.5
34		0.068	19
35		0.005	8
36		1.43	ND
37		0.11	ND